Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus‐2 disease: COVID‐19

S Rohilla - Drug development research, 2021 - Wiley Online Library
A highly contagious coronavirus disease COVID‐19 caused by a recently identified severe
acute respiratory syndrome CoV‐2 (SARS‐CoV‐2) initially detected in Wuhan, China has …

Review of emerging pharmacotherapy for the treatment of coronavirus disease 2019

A Barlow, KM Landolf, B Barlow… - … : The Journal of …, 2020 - Wiley Online Library
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
evolved into an emergent global pandemic. Coronavirus disease 2019 (COVID‐19) can …

COVID-19 outbreak and emerging management through pharmaceutical therapeutic strategy

MH Rahman, R Akter, T Behl… - Current …, 2020 - ingentaconnect.com
The latest SARS COV2 coronavirus contributes to a pandemic of millions of COVID-19. As
there is no defensive immunity in humans and a virus can overcome inborn immune …

A comprehensive updated review on SARS‐CoV‐2 and COVID‐19

YR Ren, A Golding, A Sorbello, P Ji… - The Journal of …, 2020 - Wiley Online Library
This literature review aims to provide a comprehensive current summary of the
pathogenesis, clinical features, disease course, host immune responses, and current …

[HTML][HTML] SARS-coV-2 treatment approaches: numerous options, no certainty for a versatile virus

S Iacob, DG Iacob - Frontiers in Pharmacology, 2020 - frontiersin.org
SARS-CoV-2 is the most recent coronavirus which crossed the species barrier in 2019 and
provoked a still ongoing and dangerous pandemic known as coronavirus disease 2019 …

Current scenario and future prospect in the management of COVID-19

P Borah, PK Deb, S Deka… - Current medicinal …, 2021 - ingentaconnect.com
The COVID-19 pandemic continues to wreak havoc worldwide due to the lack of risk
assessment, rapid spreading ability, and propensity to precipitate severe disease in …

Clinical characteristics, diagnosis, and therapeutics of COVID-19: a review

N Xie, W Zhang, J Chen, F Tian, J Song - Current Medical Science, 2023 - Springer
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that suddenly
emerged at the end of December 2019 and caused coronavirus disease 2019 (COVID-19) …

[HTML][HTML] Pharmacological Treatment for the Management of COVID-19: A Narrative Review

N Dhakal, A Poudyal, P Gyanwali - JNMA: Journal of the Nepal …, 2021 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 infections are alarming worldwide
incurring tremendous loss of life and possession. Individuals are facing a terrible pandemic …

COVID-19, SARS-CoV-2, origin, transmission and treatment aspects, a brief review

S Nawaz - Infectious Disorders-Drug Targets (Formerly Current …, 2021 - ingentaconnect.com
The emergence of Severe Acute Respiratory Syndrome (SARS) in named as corona virus
disease 19 (covid-19) caused by the novel corona virus SARS-CoV-2 has caused hundreds …

Advances in the possible treatment of COVID-19: A review.

P Chibber, SA Haq, I Ahmed, NI Andrabi… - European journal of …, 2020 - Elsevier
The emergence of the global pandemic caused by novel severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has put a challenge to identify or derive the therapeutics for its …